BioSpace News Archive

It is important to remember that this is a new virus, so researchers are constantly learning more about it every day.

On May 5, the company issued a statement describing their efforts.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 6, 2020.

Pharma and life sciences companies from across the globe provide updates on their business and pipelines.

The therapy is being developed to decrease C. difficile (C. diff) infection recurrences.

The CD19-directed chimeric antigen receptor (CAR) T cell therapy is a treatment for adults with relapsed or refractory large B-cell lymphoma after at least two prior therapies.

The drug can potentially reduce the risk of cardiovascular death and hospitalization for heart failure.

Developed by Novartis, the drug, Tabrecta, is designed for a type of NSCLC that has spread to other parts of the body and cannot be removed by surgery.

The U.S. Federal Trade Commission gave the green light to the $63 billion merger of AbbVie and Allergan. That leaves one last hurdle for the two companies, approval from the Irish High Court.

Vaccine expert Rick Bright, who was abruptly dismissed from his post as director of the Biomedical Advanced Research and Development Authority (BARDA) last month, filed a whistleblower complaint against the administration over its failures to heed warnings about the COVID-19 pandemic and accused the White House of cronyism in awarding contracts.